Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, GA

Clinical Trial Details

Overview

Research Study Summary

Tardive Dyskinesia in Schizophrenic Patients

Purpose

NeuroTrials Research is conducting a study to determine the effectiveness of an investigational drug on the involuntary repetitive body movements known as tardive dyskinesia in individuals with schizophrenia or schizoaffective disorder. Qualified participants receive all study-related care and study drug at no cost, and compensation is available for time and travel.

Call (404) 851-9934 or visit www.neurotrials.com

Patient Inclusion Criteria:

  • You may qualify if you:
    • are 18-65
    • have a diagnosis of schizophrenia or schizoaffective disorder
    • have a diagnosis of tardive dyskinesia
    • are otherwise in good health

Patient Exclusion Criteria:

  • See inclusions.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

NeuroTrials Research, Inc.
1100 Johnson Ferry Road, Suite 420
Atlanta, GA 30342
Phone: 404-851-9934

View Map

Research Center Information: NeuroTrials Research, Inc.

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 183396

Date Last Changed: July 16, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.